Acute Porphyria Drug Database

Monograph

B01AC13 - Abciximab
Not porphyrinogenic
NP

Rationale
Polypeptide. No CYP-interactions.
Chemical description
Fab-fragment of the chimeric monoclonal antibody 7E3, binds to and blocks a platelet surface receptor. Used together with ASA and heparin as i.v. infusion 0.25 mg/kg BW, in percutaneous coronary intervention.
Similar drugs
Explore alternative drugs in similar therapeutic classes B01A / B01AC or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


ReoPro
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙